Agility Life Sciences

We are an award-winning formulation development CDMO, focussed on accelerating your milestones and futureproofing your products. Futureproof your formulations, fast. We develop formulations to give badly behaved molecules the best chance of success in preclinical studies, and enable them to be accelerated to clinic or commercialisation. Our Fast Futureproof Formulations approach means that before we embark on a development project, we consider: The molecule: What are the properties of the molecule which we need to formulate around/out (for example, poor solubility and/or permeability)? The endgame: Where does the client want to take the product. e.g. GLP tox, Phase I, commercial?...

Pharmaceuticals,formulation,cdmo,analytical development,solubility,permeability,ocular,intravenous,intranasal,controlled release,modified release,tablets,capsules,liquids,injectables,creams,spray drying,sustained release,and subcutaneous

Agility life sciences operates in the Pharmaceutical manufacturing industry.

Agility life sciences's revenue is 11m - 100m

Agility life sciences has 11 - 50 employees.